Results 261 to 270 of about 523,619 (399)

Light‐Responsive Enzyme‐Loaded Nanoparticles for Tunable Adhesion and Mechanical Wound Contraction

Advanced Functional Materials, EarlyView.
This study presents a photoactivatable enzyme‐loaded mesoporous nanoparticle system (MPDA_PaTy) that enables light‐triggered tunable tissue adhesion and facilitates mechanical wound contraction. Controlled enzymatic crosslinking at tissue or hydrogel interfaces allows on‐demand adhesion.
Junghyeon Ko, Hyeon‐Jin Kim, Jeong‐Uk Kim, Seh Ri Oh, Tae Hoon Kang, Junghwan Byun, Uk‐Jae Lee, Minglin Ma, Su‐Hwan Kim, Byung‐Gee Kim, Nathaniel S. Hwang   +10 more
wiley   +1 more source

Early Postoperative Increase in Transforming Growth Factor Beta-1 Predicts Microvascular Flap Loss in Reconstructive Surgery: A Prospective Cohort Study. [PDF]

Medicina (Kaunas)
Rocans RP, Zarins J, Bine E, Mahauri I, Deksnis R, Citovica M, Donina S, Gravelsina S, Vilmane A, Rasa-Dzelzkaleja S, Sabelnikovs O, Mamaja B.   +11 more
europepmc   +1 more source

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.

Proceedings of the National Academy of Sciences of the United States of America, 1992
A. Miller, O. Lider, A. Roberts, M. Sporn, H. Weiner   +4 more
semanticscholar   +1 more source

Transforming growth factor beta-1 An important biomarker for developing cardiovascular diseases in chronic renal failure

, 2017
Emre Avcı, Gülçin Alp Avcı, Burçin Özçelik, Şule Çoşkun Cevher, Menderes Suíçmez   +4 more
openalex   +2 more sources

A Vascular Microphysiological Model of Lung Fibrosis Reveals That Myofibroblasts and IPF Patient‐Derived Fibroblasts Impair Angiogenesis and Vasculogenesis

Advanced Functional Materials, EarlyView.
A microphysiological lung fibrosis model recapitulates myofibroblast–vascular interactions. Induced myofibroblasts and patient‐derived IPF fibroblasts impair angiogenesis and increase vascular permeability via TGF‐β1–driven signaling. Pharmacological interventions with SB 431542 and VEGF supplementation restore vascular morphology and barrier function.
Elena Cambria, Adriana Blazeski, Eunkyung Clare Ko, Tran Thai, Shania Dantes, David A. Barbie, Sarah E. Shelton, Roger D. Kamm   +7 more
wiley   +1 more source

Association between aquaporin 3 and transforming growth factor-beta 1 levels in decidual tissue and serum of patients with missed abortion. [PDF]

Front Med (Lausanne)
Yuan J, Dong J, Li W, Zu Y, Guo Y, Zhang Y, Chen Y.   +6 more
europepmc   +1 more source

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

Proceedings of the National Academy of Sciences of the United States of America, 1995
N. Sanderson, V. Factor, P. Nagy, J. Kopp, P. Kondaiah, L. Wakefield, A. Roberts, M. Sporn, S. Thorgeirsson   +8 more
semanticscholar   +1 more source

Diagnostic Effectiveness of Transforming Growth Factor Beta 1 in Assessing the Risk of Developing Graft Dysfunction in Liver Recipient Children

, 2019
Р. М. Курабекова, О. M. Tsiroulnikova, I. E. Pashkova, A. G. Olefirenko, О. Е. Гичкун, Л. В. Макарова, R. A. Monakhov, P. O. Shevchenko   +7 more
openalex   +2 more sources

Tailoring the Properties of Functional Materials With N‐Oxides

Advanced Functional Materials, EarlyView.
The properties of materials bearing N‐oxide groups are often dominated by the polar N+─O− bond. It provides hydrophilicity, selective ion‐binding, electric conductivity, or antifouling properties. Many of the underlying mechanisms have only recently been discovered, and the interest in N‐oxide materials is rapidly growing.
Timo Friedrich, Michelle Kobus, Shirin Mesgarha, Erica Moretto, Laurens Grosche, Wolfgang Maison   +5 more
wiley   +1 more source

Transforming growth factor beta (TGF-β) induces type 1 interferon signalling in systemic sclerosis keratinocytes through the chloride intracellular channel 4 (CLIC4). [PDF]

Arthritis Res Ther
Wasson CW, Dibb SL, Caballero-Ruiz B, Bamigbola IE, Di Donato S, Madourie-Clavane EM, Wells R, Kakkar V, De Lorenzis E, Bryon J, Derrett-Smith E, Denton CP, El-Sherbiny Y, Meakin PJ, Ross RL, Del Galdo F.   +15 more
europepmc   +1 more source